Your session is about to expire
← Back to Search
Procedure
Percutaneous Coronary Intervention for Cardiovascular Disease
Phase 3
Waitlist Available
Research Sponsored by Valentin Fuster
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at year 5
Awards & highlights
Study Summary
The purpose of this study is to compare 5-year mortality rates in diabetic individuals with multivessel coronary artery disease (CAD) who undergo either coronary artery bypass grafting (CABG) surgery or percutaneous coronary stenting.
Eligible Conditions
- Cardiovascular Disease
- Heart Disease
- Coronary Heart Disease
- Diabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at year 5
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at year 5
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
5-year Composite Endpoint of All-cause Mortality, Non-fatal Myocardial Infarction, and Stroke
Secondary outcome measures
All-cause Mortality
Major MACCE Rates, Including the First of One of the Following: Death, Myocardial Infarction, Stroke, or Repeat Revascularization
Rates of Individual MACCE Endpoints
Side effects data
From 2020 Phase 4 trial • 777 Patients • NCT0198536019%
Death from any cause or Initiation of dialysis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Invasive Strategy
Conservative Strategy
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Percutaneous Coronary InterventionExperimental Treatment1 Intervention
Percutaneous Coronary Intervention
Group II: Coronary Artery Bypass GraftActive Control1 Intervention
Coronary Artery Bypass Graft
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Percutaneous Coronary Intervention
2017
Completed Phase 4
~446090
Find a Location
Who is running the clinical trial?
Valentin FusterLead Sponsor
2 Previous Clinical Trials
5,739 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,835 Previous Clinical Trials
47,308,742 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger